anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
Sarcopenia, the age-associated decline in skeletal muscle mass and strength, is a condition with a complex pathophysiology. Among the factors underlying the development of sarcopenia are the progressive demise of motor neurons, the transition from fast to slow myosin isoform (type II to type I fiber switch), and the decrease in satellite cell number and function. Mitochondrial dysfunction has been indicated as a key contributor to skeletal myocyte decline and loss of physical performance with aging. Several systems have been implicated in the regulation of muscle plasticity and trophism such as the fine-tuned and complex regulation between the stimulator of protein synthesis, mechanistic target of rapamycin (mTOR), and the inhibitor of mTOR, AMP-activated protein kinase (AMPK), that promotes muscle catabolism. Here, we provide an overview of the molecular mechanisms linking mitochondrial signaling and quality with muscle homeostasis and performance and discuss the main pathways elicited by their imbalance during age-related muscle wasting. We also discuss lifestyle interventions (i.e., physical exercise and nutrition) that may be exploited to preserve mitochondrial function in the aged muscle. Finally, we illustrate the emerging possibility of rescuing muscle tissue homeostasis through mitochondrial transplantation.
This study was designed to examine the validity and reliability of the Turkish version of the Children Participation Assessment Scale. Translation and cultural adaptation of the questionnaire will be designed according to an appropriate procedure. The original English version of the questionnaire is fluent in English; It will be translated into Turkish by two people, one a physiotherapist and the other a linguist. Translators will come together and combine the questionnaires translated into Turkish into a single translation. The questionnaire translated into Turkish will then be translated back into English by two sworn translators whose mother tongue is English and who know Turkish well. The questionnaire, which was translated from Turkish to English again, will be synthesized by the translation team and turned into a single translation and its compatibility with the original will be evaluated. 250 children between the ages of 6 and 12 with physical disabilities and their parents will be included in this study. Children and parents with serious visual and auditory problems and who do not volunteer to participate in the study will be excluded from the study. While examining the validity of the scale in children, it was planned to use the Child Health Questionnaire scale, which had previously been shown to be reliable and valid in healthy children with different disability levels. The questions in the data collection form will be asked to the parents in the form of face-to-face interviews.
Standard of care (SoC): The subjects in the SoC group continued with conventional treatment i.e. using pads during week 1, 2 and 3. They were offered to use the TVS device for two weeks after completion of week 3.
This application relates to the production and characterization of a mutant strain of  Aspergillus fumigatus . The application also relates to a method for inhibiting siderophore biosynthesis in  Aspergillus fumigatus  and an assay for identifying drug candidates or other agents having potential inhibitory activity. The method may comprise, for example, the step of inhibiting an enzyme catalyzing siderophore biosynthesis, such as L-ornithine N 5 -oxygenase. In one embodiment the siderophore is a hydroxamate siderophore, such as N′N″N′″-triacetylfusarinine C (TAF) or ferricrocin. A method of preventing or treating fungal infections in a patient is also described comprising administering to the patient an agent suitable for inhibiting fungal secretion of siderophores. The method is particularly useful for immunocompromised patients susceptible to fungal infections caused by  Aspergillus fumigatus , such as pulmonary aspergillosis. The invention also relates to diagnostic methods for detecting a biomarker indicative of likely  A fumigatus  infection in vivo, such as serum presence of TAF.
With increasing survival of women treated for breast cancer, it becomes necessary to evaluate the effect of therapeutic resources in morbidity due to surgical treatment of breast cancer. The objective of this study is to evaluate the effect of elastic compression, functional compressive bandaging (ECF) and active exercises in the bloodstream of the upper member ipsilateral to the surgical procedure for the treatment of breast cancer. The study will be conducted according to design random cross over and wash out period of 7 days. They will be evaluated 30 volunteers aged between 45 and 70 years, submitted to treatment of breast cancer. The volunteers will be submitted to three different therapeutic procedures applied randomly by lot: active exercises, functional compressive bandaging with active exercises and elastic compression with active exercises. The profile of blood flow, including speed and direction, will be assessed by Doppler ultrasound before and after, at 0, 15, 30 minutes. Normality will be verified by the Shapiro-Wilk test, and the effect of behavior between pre- and post-intervention will be evaluated by ANOVA two-way followed by post-hoc test Friedman followed rank, p \<0.05 . The data obtained in the study are intended to enhance the forms of physical therapy intervention in the face of circulatory morbidities resulting from breast cancer treatments.
Methods of making room temperature-curable polymers. Reactants include siloxane-terminated polymers and silanols. The reactants are mixed, and the polymerization allowed to proceed in air at room temperature. The polymers are exceptionally useful because they allow for the incorporation into the polymers themselves of one or more therapeutic compounds. Thus, medical devices from which controlled drug release is desirable (for either local or systemic delivery) can be coated with therapeutic compound-containing polymers of the invention. In a preferred embodiment, a polymer of poly(MPC w :LAM x :HPMA y :TSMA z ) where w, x, y, and z represent the molar ratios of monomers used in the feed for preparing the polymer; MPC represents the unit  2 -methacryoyloxyethylphosphorylcholine, LMA represents the unit lauryl methacrylate, HPMA represents the unit  2 -hydroxypropyl methacrylate, and TSMA represents the unit  3 -trimethoxysilylpropyl methacrylate is reacted with polydimethylsiloxane. In another preferred embodiment, a therapeutic compound is incorporated into the polymer, such as dexamethasone.
Objective. Identifying the seizure occurrence period (SOP) in extended EEG recordings is crucial for neurologists to diagnose seizures effectively. However, many existing computer-aided diagnosis systems for epileptic seizure detection (ESD) primarily focus on distinguishing between ictal and interictal states in EEG recordings. This focus has limited their application in clinical settings, as these systems typically rely on supervised learning approaches that require labeled data.Approach. To address this, our study introduces an unsupervised learning framework for ESD using a 1D- cascaded convolutional autoencoder (1D-CasCAE). In this approach, EEG recordings from selected patients in the CHB-MIT datasets are first segmented into 5 s epochs. Eight informative channels are chosen based on the correlation coefficient and Shannon entropy. The 1D-CasCAE is designed to autonomously learn the characteristic patterns of interictal (non-seizure) segments through downsampling and upsampling processes. The integration of adaptive thresholding and a moving window significantly enhances the model's robustness, enabling it to accurately identify ictal segments in long EEG recordings.Main results. Experimental results demonstrate that the proposed 1D-CasCAE effectively learns normal EEG signal patterns and efficiently detects anomalies (ictal segments) using reconstruction errors. When compared with other leading methods in anomaly detection, our model exhibits superior performance, as evidenced by its average Gmean, sensitivity, specificity, precision, and false positive rate scores of 98.00% ± 3.51%, 94.94% ± 6.92%, 99.60% ± 0.30%, 79.92% ± 13.56% and 0.0044 ± 0.0030 h-1respectively for a typical patient in CHB-MIT datasets.Significance. The developed model framework can be employed in clinical settings, replacing the manual inspection process of EEG signals by neurologists. Furthermore, the proposed automated system can adapt to each patient's SOP through the use of variable time windows for seizure detection.
Topical gentamicin; Topical gentamicin with microneedle roller assistance; IV gentamicin. While the intervention is the same drug, the topical gentamicin is compounded into a 0.5% ointment and the IV gentamicin is prepared to 7.5 mg/kg body weight and administered over a 30 minutes.
FIELD: medicine, pharmacy. SUBSTANCE: invention relates to compositions as microcapsules or implants. Compositions comprise excipient or mixture of biodegradable polymeric or copolymeric excipients with intrinsic viscosity from 0.5 dl/g to 1.6 dl/g in medium of CHCl 3 . Compositions comprise protein or peptide as active substance. Compositions provide release of indicated active substance for the prolonged time that can attain 3 months or more and they exhibit monophase pattern of release of active substance being without the initial period. EFFECT: improved method of preparing, improved properties of compositions. 24 cl, 6 tbl, 16 ex
MB-102 and iohexol administered to participants with impaired renal function (chronic kidney disease (CKD) Stage 3-4), and fluorescence measured by the QuantumLeap ORFM device. Approximately half of the participants were to be enrolled with Fitzpatrick Scale Type I, II or III, and half with Type IV, V and VI skin color type. In order to determine the optimal dose of MB-102, participants may have received different doses.
Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome is an extremely rare disorder of urea cycle, with few patients reported worldwide. Despite hyperammonemia control, the long-term outcome remains poor with progressive neurological deterioration. We report the clinical, biochemical, and molecular features of two Lebanese siblings diagnosed with this disorder and followed for 8 and 15 years, respectively. Variable clinical manifestations and neurological outcome were observed. The patient with earlier onset of symptoms had a severe neurological deterioration while the other developed a milder form of the disease at an older age. Diagnosis was challenging in the absence of the complete biochemical triad and the non-specific clinical presentations. Whole exome sequencing revealed a homozygous variant, p.Phe188del, in the SLC25A15 gene, a French- Canadian founder mutation previously unreported in Arab patients. Hyperammonemia was controlled in both patients but hyperonithinemia persisted. Frequent hyperalaninemia spikes and lactic acidosis occured concomitantly with the onset of seizures in one of the siblings. Variable neurological deterioration and outcome were observed within the same family. This is the first report from the Arab population of the long-term outcome of this devastating neurometabolic disorder.
Patients will receive particle radiotherapy in arm down position. Radiation: adjuvant hypofractionated intensity-modulated proton radiotherapy; For patients received modified radical mastectomy, CTV1: chest wall ± regional lymph drainage area, 40.05Gy (RBE) in 15 fractions with proton radiotherapy; For patients received lumpectomy, CTV1: whole breast ± regional lymph drainage area, 40.05 Gy (RBE) in 15 fractions with proton radiotherapy; CTVtb: tumor bed SIB to 48 Gy (RBE) in 15 fractions with proton radiotherapy.
Cell surface receptors play crucial roles in cellular responses to extracellular ligands, helping to modulate the functions of a cell based on information coming from outside the cell. Syndecan refers to a family of cell adhesion receptors that regulate both extracellular and cytosolic events. Alteration of syndecan expression disrupts regulatory mechanisms in a cell type-specific fashion, often leading to serious diseases, notably cancer. Given the multifaceted functions and distinct tissue distributions of syndecan, it will be important to unravel the gene-level intricacies of syndecan expression and thereby further understand its involvement in various carcinogenic processes. Although accumulating evidence indicates that the protein expression patterns of syndecan family members are significantly altered in cancer cells, the underlying gene-level mechanisms remain largely unknown. This review endeavors to explore syndecan gene expression levels across different cancer types by scrutinizing extensive cancer genome datasets using tools such as cBioPortal. Our analysis unveils that somatic mutations in SDC genes are rare occurrences, whereas copy number alterations are frequently observed across diverse cancers, particularly in SDC2 and SDC4. Notably, amplifications of SDC2 and SDC4 correlate with heightened metastatic potential and dismal prognosis. This underscores the recurrent nature of SDC2 and SDC4 amplifications during carcinogenesis and sheds light on their role in promoting cancer activity through augmented protein expression. The identification of these amplifications not only enriches our understanding of carcinogenic mechanisms but also hints at the potential therapeutic avenue of targeting SDC2 and SDC4 to curb cancer cell proliferation and metastasis.
INTRODUCTION: Post-stroke fatigue (PSF) has been described as early exhaustion with tiredness that develops during physical or mental activity and generally does not improve with rest. There are inconsistent findings on the relationship between the characteristics of the ischemic brain lesion and PSF. However, some studies suggest that specific neuroanatomical and neuroplastic changes could explain post-stroke fatigue. The aim was to evaluate the severity of PSF in relation to the location and the size of the ischemic lesion in acute stroke patients to establish possible predictors of PSF.
PATIENTS AND METHODS: We performed a prospective observational study to establish potential early predictors of long-term PSF, which was assessed using the Fatigue Assessment Scale six months after ischemic stroke. After segmenting brain infarcts on Diffusion-Weighted Imaging (DWI) images, we studied the association with PSF using Voxel-Based Lesion-Symptom Mapping (VLSM).
RESULTS: Out of 104 patients, 61 (59 %) reported PSF. Female sex and history of diabetes mellitus were associated with a greater risk of developing PSF. The association of PSF with female sex was confirmed in a replication cohort of 50 patients. The ischemic lesion volume was not associated with PSF, and VBLSM analysis did not identify any specific brain area significantly associated with PSF.
CONCLUSIONS: PSF is frequent in stroke patients, especially women, even after six months. The absence of neuroanatomical correlates of PSF suggests that it is a multifactorial process with biological, psychological, and social risk factors that require further study.
Accidental overdose may lead to hemorrhagic complications. There is no antidote to dabigatran etexilate or dabigatran. In the event of hemorrhagic complications, initiate appropriate clinical support, discontinue treatment with PRADAXA, and investigate the source of bleeding. Dabigatran is primarily excreted in the urine; therefore, maintain adequate diuresis. Dabigatran can be dialyzed (protein binding is low), with the removal of about 60% of drug over 2 to 3 hours; however, data supporting this approach are limited. Consider surgical hemostasis or the transfusion of fresh frozen plasma or red blood cells. There is some experimental evidence to support the role of activated prothrombin complex concentrates (e.g., FEIBA), or recombinant Factor VIIa, or concentrates of coagulation factors II, IX or X; however, their usefulness in clinical settings has not been established. Consider administration of platelet concentrates in cases where thrombocytopenia is present or long-acting antiplatelet drugs have been used. Measurement of aPTT or ECT may help guide therapy [see Clinical Pharmacology (12.2)].
Standard endovascular treatment (stenting) in patients with the iliac segment occlusive disease. Medication: after stenting all patients are prescribed long-term aspirin (100 mg daily) and clopidogrel for 3 months (75 mg daily).
OBJECTIVE: Accurate prediction of survival prognosis is helpful to guide clinical decision-making. The aim of this study was to develop a model using machine learning techniques to predict the occurrence of composite thromboembolic events (CTEs) in elderly patients with atrial fibrillation(AF). These events encompass newly diagnosed cerebral ischemia events, cardiovascular events, pulmonary embolism, and lower extremity arterial embolism.
METHODS: This retrospective study included 6,079 elderly hospitalized patients (≥ 75 years old) with AF admitted to the People's Liberation Army General Hospital in China from January 2010 to June 2022. Random forest imputation was used for handling missing data. In the descriptive statistics section, patients were divided into two groups based on the occurrence of CTEs, and differences between the two groups were analyzed using chi-square tests for categorical variables and rank-sum tests for continuous variables. In the machine learning section, the patients were randomly divided into a training dataset (n = 4,225) and a validation dataset (n = 1,824) in a 7:3 ratio. Four machine learning models (logistic regression, decision tree, random forest, XGBoost) were trained on the training dataset and validated on the validation dataset.
RESULTS: The incidence of composite thromboembolic events was 19.53%. The Least Absolute Shrinkage and Selection Operator (LASSO) method, using 5-fold cross-validation, was applied to the training dataset and identified a total of 18 features that exhibited a significant association with the occurrence of CTEs. The random forest model outperformed other models in terms of area under the curve (ACC: 0.9144, SEN: 0.7725, SPE: 0.9489, AUC: 0.927, 95% CI: 0.9105-0.9443). The random forest model also showed good clinical validity based on the clinical decision curve. The Shapley Additive exPlanations (SHAP) showed that the top five features associated with the model were history of ischemic stroke, high triglyceride (TG), high total cholesterol (TC), high plasma D-dimer, age.
CONCLUSIONS: This study proposes an accurate model to stratify patients with a high risk of CTEs. The random forest model has good performance. History of ischemic stroke, age, high TG, high TC and high plasma D-Dimer may be correlated with CTEs.
In the hospice ward, there are lots of suffered hospital patients with multiple physical discomfort related to terminal disease. It may be caused by cancer or multiple kinds of organ failure. The terminal hospital patients have symptoms such as pain, dyspnea, fatigue, nausea, vomiting, poor appetite, constipation, ileus or edema..., etc. Investigators want to use an objective measure instrument to monitor the effects of complementary and alternative medicine.

First, investigators use the Meridian Energy Analysis Device (MEAD) to measure the bilateral 12 Yuan points (primary points) of terminal hospice patients (divided to cancer, multiple kinds of organ failure). It provides the prediction value between terminal disease and the change of different meridian energy. Besides, the meridian energy value maybe predict the survival period. Then, investigators use the intervention of complementary and alternative medicine (like infrared lamp and acupressure..., etc.) to improve the quality of life in the terminal hospice patients. Also, investigators will use the Meridian Energy Analysis Device, pain scale, vital signs and quality of life scale (SF-36) to evaluate the effects of complementary and alternative medicine.
PURPOSE:Phospholipid is dispersed in an aqueous medium, freeze-dried and dispersed in an aqueous medium containing an active ingredient again to produce the titled preparation used as a support for adjusting the absorption of the active ingredient by no use of an organic solvent. CONSTITUTION:A phospholipid, originating from yolk, soybean, other animal of plant tissues such as phosphatidylcholine or sphingomyelins or their mixture, is dispersed in an aqueous medium such as an aqueous solution of sodium chloride or a shaccharide. Then, the dispersion is freeze-dried at -20--50 deg.C. The resultant freeze-dried product is dispersed again in an aqueous medium containing an active ingredient to produce the titled preparation. Examples of the above active ingredient are diltiazem, glutathion, vitamins, enzyme preparation such as L-asparginase. The weight ratio of the active ingredient to the phospholipid in the freeze-dried product is 1pt/(5-100)pts. preferably.
All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications, most notably longer time on the breathing machine and in the ICU. Two strategies have been shown to dramatically improve patient outcomes: nurse-directed protocols for giving sedation, and daily interruption of sedation. However, these strategies have not been widely adopted, because of physicians' concerns, and because it is unclear which strategy is better. Given that patient outcome is improved with either of these strategies, the fundamental question that arises is whether patients managed with a combination of two strategies which both reduce drug accumulation (protocolized sedation and daily interruption) have an even better outcome than patients managed with only one of them (protocolized sedation).We are conducting a multicenter randomized trial in which 400 critically ill, mechanically ventilated patients will have their sedation managed with protocolized sedation alone, or both strategies. Primary outcomes are duration of mechanical ventilation and ICU and hospital lengths of stay. Secondary outcomes are the incidence of delirium, the use of neurologic tests, nurse and respiratory therapist effort associated with the sedation management, the incidence of patient self-removal of lines and tubes, and patient recall of the ICU stay. The results of this large multi-center trial will help to inform best practice with regard to sedation management of critically ill patients in Canada and elsewhere.
The invention discloses Qingpeng plaster for relieving pain and eliminating swelling. The Qingpeng plaster is prepared by changing auxiliary materials based on the prescription of traditional Tibetan medicine Qingpeng ointment. The Qingpeng plaster is convenient to carry and use, and has the advantages of strong penetration, remarkable curative effects, and the like. The Qingpeng plaster prepared by the preparation method does not contain any chemosynthetic stabilizing agent, thus being safe to use. In the preparation method, partial medicinal materials are extracted and partial medicinal materials are fried thus effectively preserving active ingredients in the medicinal materials, greatly improving the content of crude medicine material ingredients, improving the bioavailability, and achieving preferable curative effects. The medicine effect experiments prove that the Qingpeng plaster has the obvious effects of relieving pain and eliminating swelling.